Our results showed that the EMT marker E-cadherin expression was significantly increased, and N-cadherin as well as Vimentin was significantly decreased after knockdown of HHLA2 expression, suggesting that HHLA2 was involved in the cancer progression of human ccRCC by promoting EMT. The gene discussed is HHLA2; the disease is nonpapillary renal cell carcinoma.